| HS Code | |
| Productname | Sucralose |
| Chemicalname | 1,6-Dichloro-1,6-dideoxy-β-D-fructofuranosyl-4-chloro-4-deoxy-α-D-galactopyranoside |
| Synonyms | Trichlorosucrose; 4,1',6'-Trichlorogalactosucrose |
| Casnumber | 56038-13-2 |
| Einecsnumber | 259-952-2 |
| Enumber | E955 |
| Insnumber | 955 |
| Molecularformula | C12H19Cl3O8 |
| Molecularweight | 397.64 g/mol |
| Appearance | White crystalline powder |
| Odor | Odorless |
| Taste | Sweet |
| Sweetness | About 600 times sweeter than sucrose |
| Solubility | Soluble in water, methanol, and ethanol; slightly soluble in ethyl acetate |
| Meltingpoint | 125 °C with decomposition |
| Density | 1.66 g/cm³ |
| Ph | 5.0 to 7.0 for a 10% aqueous solution |
| Assay | 98.0% to 102.0% |
| Specificrotation | [α]D20 = +84° to +88° |
| Moisture | ≤0.5% |
| Ash | ≤0.1% |
| Heavymetals | ≤10 ppm |
| Arsenic | ≤3 ppm |
| Caloricvalue | 0 kcal/g |
| Glycemicindex | 0 |
| Dentalcaries | Non-cariogenic |
| Heatstability | Stable at baking temperatures |
| Phstability | Stable over a wide pH range |
| Storage | Store in a cool, dry place away from direct sunlight |
| Shelflife | 2 years in unopened original packaging |
| Packaging | 25 kg fiber drum, bulk bags, or retail packets |
| Regulatorystatus | Approved as a food additive in many countries |
| Usage | Non-nutritive sweetener for foods and beverages |
As an accredited Sucralose factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Sucralose is supplied in a sealed 500 g double-lined polyethylene bag inside a fiber drum for industrial use. |
| Container Loading (20′ FCL) | 20′ FCL container fully loaded with Sucralose in sealed drums on pallets, securely braced, moisture-controlled, and shipped with compliant documentation. |
| Shipping | Sucralose is generally shipped as a non-hazardous, food-grade powder in sealed polyethylene-lined bags, fiber drums, or cartons. Keep dry, away from strong odors, at ambient temperature. It is not classified as dangerous goods; follow local food, chemical transport, and hygiene regulations. Ensure containers stay closed and labeled. |
| Storage | Store sucralose in a cool, dry, well-ventilated area in a tightly sealed container. Protect from moisture, heat, and direct sunlight. Keep away from strong oxidizing agents and sources of ignition. Avoid generating dust. Use appropriate secondary containment to prevent spills. Store separately from incompatible materials. Maintain clear labels and follow local regulations and safety data sheet recommendations. Ensure containers are closed. |
| Shelf Life | Sucralose has a long shelf life, typically two years or more when stored dry and cool, away from moisture and heat. |
Sucralose (CAS 56038-13-2) is introduced into zero-sugar carbonated soft drink and still beverage lines as a non-sucrose sweetness component after syrup blending and before carbonation. Finished-beverage dosing typically falls between 60 mg/L and 150 mg/L when combined with acesulfame potassium at a ratio of 2.5:1 to 3:1; this combination shortens sweetness onset and reduces total high-intensity sweetener load. The United States permits sucralose as a general-purpose sweetener under 21 CFR 172.831; the European Union lists the additive as E 955 in Regulation (EC) No 1333/2008 Annex II Part E, and Codex Alimentarius GSFA food category 14.1.4 sets a maximum level of 300 mg/kg for sucralose in water-based flavoured drinks. Production doses remain materially below the Codex maximum because excessive sucralose produces a lingering sweet aftertaste that cannot be fully corrected by acidifier addition. In a typical carbonated soft drink process, a 20–25% w/v sucralose stock solution is prepared in hot demineralised water at 60–70 °C, passed through a 100 µm bag filter, and metered into the sugar-free syrup stream by a positive displacement pump with flow accuracy of ±2%. The syrup is flash-pasteurised at 95–105 °C for 15–30 s, cooled to 2–4 °C, and carbonated in a stainless steel receiver at 3.5–4.5 bar CO₂ partial pressure. Finished beverage pH is held between 2.8 and 3.5, conditions under which sucralose undergoes no detectable hydrolysis during the shelf-life window. Batch-to-batch dosage drift can occur when the stock solution is left unagitated for more than 8 h; concentrated sweetener can settle at the tank bottom, producing early-batch sweetness deviation. Terminal product categories include zero-sugar cola, lemon-lime carbonated drinks, sugar-free energy drinks, isotonic beverages, flavoured sparkling water, and powdered soft-drink concentrates.
Sucralose is neither fermented nor consumed by Streptococcus thermophilus and Lactobacillus delbrueckii subsp. bulgaricus in yogurt starter systems, so sweetness retention after incubation is effectively complete. In flavoured yogurt and fermented dairy beverages, typical addition is 25 mg/kg to 100 mg/kg; fruit preparations designed for incorporation at 10–15% w/w into a sweetened base may contain 120–250 mg/kg to replace sucrose removed from the fruit phase. The legal basis includes 21 CFR 172.831 and Regulation (EC) No 1333/2008 Annex II Part E, under which sucralose is authorised for fermented milk products and flavoured drinks within the relevant Union food categories. In UHT dairy drink processing, the base is preheated to 75–80 °C, homogenised in a two-stage valve system at 150–220 bar total pressure, heated to 135–138 °C for 4 s, and flash-cooled to 25 °C before aseptic filling. Sucralose can be added before heat treatment as an aqueous solution or as a dry pre-blend with skimmed milk powder without significant assay loss. In fermented lines, milk is pasteurised at 90–95 °C for 5–10 min, homogenised, cooled to 42–43 °C, inoculated, and held until pH reaches 4.2–4.5; sucralose is stable throughout this pH and time profile. For acidified dairy desserts stored above 35 °C at pH below 3.0, published data for the specific fruit-dairy-sweetener matrix are limited, so stability testing on the finished formulation is required. Terminal products include no-added-sugar stirred yogurt, set yogurt, drinking yogurt, kefir, high-protein dairy desserts, and reduced-sugar ice cream base.
In reduced-sugar fine bakery goods, sucralose is used at 100–300 mg/kg of finished product when it is the sole sweetener, or at 0.02–0.06% w/w in dry dough/batter mixes where maltodextrin, polydextrose, erythritol, or maltitol restores osmotic and bulking roles. The addition is governed in the United States by 21 CFR 172.831; in the EU, Regulation (EC) No 1333/2008 Annex II Part E establishes maximum levels for fine bakery ware in food category 07.2, and Codex GSFA commodity provisions apply in many export jurisdictions. Sucralose does not provide the reducing sugar groups required for Maillard browning, so crust colour adjustment in sugar-free bakery goods is a necessary formulation step. A process-suitable method is to pre-blend sucralose with a low-moisture carrier such as maltodextrin DE 10–18 at a ratio of 1:9 to 1:19 before introduction into the fat phase of a planetary mixer. Dough or batter temperature is controlled at 20–26 °C to limit fat smearing and prevent premature starch gelatinisation. Tunnel ovens with zone setpoints between 160 °C and 210 °C and residence times of 8–15 min are common; the absence of sucrose alters water activity during starch gelation, which can change crumb firming and retrogradation. In sugar-free cakes, replacement of sucrose with a sucralose–polydextrose system may require addition of 1.0–2.5% pregelatinised starch to control moisture migration. On high-speed dry-mix lines, neat sucralose powders with particles below 100 µm can segregate during pneumatic transfer; carrier pre-blending is used to minimise assay variation. Terminal products include soft cakes, muffins, cookies, cereal bars, breakfast biscuits, and sugar-free wafer fillings.
Pharmaceutical oral liquid development uses sucralose under compendial excipient control rather than food-additive norms alone. The current USP-NF Sucralose monograph includes identity, assay, specific rotation, and related substances criteria; release specifications in pharmaceutical supply chains are expected to align with this monograph and with ICH Q3C residual solvent limits where relevant. The FDA Inactive Ingredient Database reports sucralose use in oral solutions and syrups at levels generally between 0.05% w/w and 0.40% w/w; orodispersible and chewable formats may use 0.1–0.5% w/w to mask highly bitter APIs. In syrup manufacturing, sucralose is dissolved in purified water at 25–35 °C under moderate agitation for 10–15 min, then added to a base containing sorbitol solution (70% w/w), glycerol, citrate buffer, and preservative. The syrup is adjusted to pH 4.0–6.0 and cooled to 20–25 °C before heat-labile API addition. Prolonged exposure above pH 7.5 and 40 °C is avoided in development because sucralose hydrolytic stability decreases outside the weakly acidic to neutral range. For dry reconstitutable suspensions, sucralose is dry-blended with active and bulking agents in a V-blender for 15–20 min; blend uniformity is assessed at not fewer than 10 sampling positions. Terminal product types include pediatric antibiotic suspensions, antihistamine syrups, antacid suspensions, zinc and vitamin syrups, orodispersible tablets, and chewable antacid tablets.
Oral care manufacturing uses sucralose at levels that avoid dosage-dependent thinning of silica toothpaste matrices. In a typical toothpaste, sucralose is incorporated at 0.05% w/w to 0.25% w/w; alcohol-free mouthrinse formulations generally use 0.01% w/w to 0.05% w/w, which is sufficient because the sweet taste is evaluated against a low-solids aqueous background. The product standard ISO 11609:2017 for dentifrices specifies abrasivity, fluoride availability, and stability requirements; where the oral care product is a cosmetic rather than a medical device, Regulation (EC) No 1223/2009 applies to the finished formula, while the food additive status of sucralose under 21 CFR 172.831 and E 955 remains relevant to toxicological risk assessment. Sucralose is not fermented by Streptococcus mutans or other oral plaque microorganisms, so the additive does not contribute to fermentable saccharide load. In processing, sucralose is first dispersed into the sorbitol–glycerol humectant phase before silica abrasive addition; direct introduction into the dry abrasive phase can produce localised stratification and incomplete dissolution. Vacuum mixing at -0.08 MPa to -0.10 MPa is maintained to prevent air entrapment; subsequent flavour addition and homogenisation are unchanged. In mouthrinse compounding, a sucralose aqueous solution is added to the bulk tank after the solvent phase and before final pH adjustment to 6.0–7.5. Above approximately 0.35% w/w sucralose in toothpaste, rheological thinning has been observed in some carboxymethyl cellulose-thickened systems, requiring adjustment of the binder level. Terminal product types include fluoride anticaries toothpastes, whitening pastes, children’s non-fluoride pastes, alcohol-free mouthrinses, and dental gel formulations.
Protein supplement and meal replacement manufacturing applies sucralose at 0.005–0.03% w/w in dry powder blends and 0.02–0.08% w/w in ready-to-drink meal replacements, with the lower end used when the formula also contains acesulfame potassium or monk fruit extract. Compliance for dietary supplements is anchored to 21 CFR 111 current good manufacturing practice in the United States; in the EU, the finished product is governed by Directive 2002/46/EC for food supplements where applicable, while the food additive is authorised as E 955 under Regulation (EC) No 1333/2008. For conventional foods positioned as meal replacements, compositional requirements follow the market-specific food authority criteria. Dry blending uses a ribbon blender or V-blender with a sucralose pre-blend prepared by geometric dilution into a carrier such as maltodextrin, inulin, or isolated soy protein to avoid residual sweetener pockets. Because sucralose particle size can range below 100 µm, prolonged vibration on packing lines may induce segregation; therefore the pre-blend is introduced at the midpoint of the mixer cycle and blending is continued for 15–25 min after final ingredient addition. Ready-to-drink protein beverages are prepared by hydrating protein and gum stabilisers, batch-heating to 85–95 °C for 10–15 min or UHT processing at 135–140 °C for 3–6 s, homogenising at 150–250 bar, and adding the sucralose solution before final standardisation. Published stability data for sucralose in high-concentration protein-RTD matrices during long-term ambient storage are formulation-specific; accelerated shelf-life testing at 40 °C and 75% RH is used for candidate formulations. Terminal product types include whey and plant-protein shakes, meal replacement drinks, sports nutrition powders, electrolyte tablets, and clear protein beverages.
Competitive Sucralose prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8618136850665 or mail to admin@ascent-chem.com.
We will respond to you as soon as possible.
Tel: +8618136850665
Email: admin@ascent-chem.com
Flexible payment, competitive price, premium service - Inquire now!
Sucralose (CAS 56038-13-2) is the high-intensity sweetener systematically designated as 1,6-dichloro-1,6-dideoxy-β-D-fructofuranosyl-4-chloro-4-deoxy-α-D-galactopyranoside. The molecule is produced by selective chlorination of sucrose at the 4, 1′, and 6′ hydroxyl positions, yielding the empirical formula C12H19Cl3O8 and a molar mass of 397.64 g/mol. The chlorinated configuration preserves sweet-taste receptor activation while blocking hydrolysis by mammalian glycosidases; consequently, the compound is not metabolized for energy and does not elicit a glycemic response at typical use levels. Commercial product forms are differentiated as crystalline powder, micronized powder for dry-mix dispersion, and 25% w/w aqueous liquid concentrate. Model designations are supplier-specific and typically encode particle-size distribution, residual solvent profile, and certification package for Kosher, Halal, pharmaceutical, or non-GMO compliance rather than molecular differences.
Published physicochemical data for the crystalline form indicate water solubility of 283 g/L at 20°C. A 10% aqueous solution exhibits a pH range of 5–8. Optical rotation is specified from +84.0° to +87.5° at c=1 in water at 20°C. Thermal decomposition onset is reported near 125°C in dry crystalline material. The substance is non-hygroscopic under ambient conditions but may cake if stored in unsealed hoppers at relative humidity above 60%; desiccant-lined storage or forced-air dehumidification is recommended for bulk handling.
Commercial crystalline sucralose is controlled against pharmacopoeial and food-chemical monograph limits. The assay, related substances, water content, and residual solvents are typically determined by HPLC with refractive index detection, Karl Fischer titration, and headspace gas chromatography. The following limits represent the convergent specifications of USP-NF, Ph.Eur. monograph 1798, FCC, and JECFA monographs.
| Assay on dried basis | 98.0–102.0% | HPLC with refractive index detection |
| Water | ≤2.0% | Karl Fischer titration |
| Specific rotation | +84.0° to +87.5° | Polarimetry, c=1 in water, 20°C |
| Related substances | Total impurities per monograph | HPLC area normalization |
| Residue on ignition | ≤0.7% | Gravimetric analysis |
| Heavy metals | ≤10 mg/kg | ICP-MS or colorimetric method |
| Lead | ≤1 mg/kg | AAS or ICP-MS |
| Arsenic | ≤3 mg/kg | AAS or ICP-MS |
| Methanol | ≤0.1% | Headspace GC |
Regulatory authorisation is anchored to FDA 21 CFR 172.831, EU Regulation 1333/2008 Annex II as food additive E 955, and Codex Alimentarius INS 955. The EFSA acceptable daily intake is 15 mg/kg bw/day; the FDA acceptable daily intake is 5 mg/kg bw/day; the JECFA ADI is 0–15 mg/kg bw/day. Metabolic studies indicate approximately 85% of ingested sucralose is excreted unchanged in feces and approximately 15% is absorbed and excreted unchanged in urine.
In dry-blend manufacturing, crystalline sucralose is typically incorporated in ribbon blenders or plow mixers equipped with intensifier bars. Because the use rate in finished foods is often 0.01–0.20% by mass, segregation and assay drift across mixing cycles are controlled by pre-blending the sweetener with a carrier such as dextrose, maltodextrin, or citric acid at a 1:10 or 1:20 ratio. Batch-to-batch variance in particle size can shift dry-mix homogeneity; micronized grades and vibratory sieving reduce agglomerate-induced hotspots, but published data for specific carrier combinations is limited and should be verified by blend uniformity testing.
Sucralose does not provide the bulk, water-holding capacity, reducing-sugar browning, or fermentable carbohydrate function of sucrose. In sugar-reduced bakery fats, doughs, and batters, replacement of sucrose with sucralose requires compensatory addition of polydextrose, maltitol, erythritol, resistant maltodextrin, or inulin to restore starch gelatinization, gluten development, and moisture retention. In high-shear mixing equipment such as planetary mixers or twin-arm dough mixers, sucralose is preferably dispersed as a fine powder in oil or propylene glycol before addition to the aqueous phase to prevent localized concentration gradients and undissolved crystalline agglomerates.
Because sucralose lacks a reducing group, it does not undergo Maillard browning or caramelization. This is operationally significant in baked products where crust colour and roasted flavour are expected. Internal crumb temperatures in conventional baking remain near 100°C due to evaporative cooling, and sucralose retention in the crumb is generally high. Surface temperatures, however, can exceed 150°C in low-moisture regions, and localized degradation may occur; published recovery data for specific baking profiles is limited. Formulators should therefore validate sweetness retention through forced-degradation studies under actual oven conditions rather than relying on nominal thermal stability alone.
Beverage, dairy, and oral-care applications use liquid sucralose concentrate or dry crystalline material metered into high-shear mixing tanks. The sweetener is stable in aqueous systems over a pH range of 2–8 at ambient temperature. In carbonated soft drinks, stock solutions at 0.1–0.5% w/w are typically metered after flash pasteurization to avoid unnecessary thermal load. In UHT systems, exposure to 135°C for 2–5 s at neutral pH results in high retention, but acidic protein-based beverages require validation because localized pH and mineral interactions can accelerate hydrolysis. Published data for specific UHT configurations is limited; pilot-scale heat exchanger trials are recommended before commercial scale-up.
The dominant instability mechanism for sucralose is hydrolytic dechlorination at extremes of pH and temperature. At pH values above 8 and at temperatures above 120°C, loss of sweetness accelerates. Strong oxidizers and strongly alkaline conditions can release chloride and generate degradation products with reduced sweetness. The degradation pathway is pH-dependent rather than simple thermal decomposition; therefore, retorted foods with pH 6.5–7.0 may retain more sucralose than acidified foods processed under identical thermal conditions. Prolonged heating in systems containing high concentrations of reducing sugars or certain mineral salts may also produce secondary interactions that require analytical confirmation by HPLC. Because sucralose does not caramelize or participate in Maillard reactions, colour changes in processed foods cannot be used as an indicator of sweetener retention.
Sucralose differs from other high-intensity sweeteners in its organoleptic profile and processing stability. The sweetness potency is commonly reported as 600 times that of sucrose, with a functional range of 400–800 times depending on concentration, pH, temperature, and food matrix. Unlike aspartame, sucralose does not supply phenylalanine and remains stable at temperatures above 100°C. Unlike acesulfame potassium and saccharin, sucralose does not exhibit a pronounced bitter or metallic side taste at high concentrations. Compared with steviol glycosides, sucralose has a faster sweetness onset and less lingering licorice-like aftertaste.
| Sweetener | Sweetness potency vs sucrose | Thermal stability | Primary organoleptic or functional limitation | Regulatory reference |
| Sucralose | 400–800× | Stable at pH 2–8; decomposition near 125°C | No bulk, browning, or fermentation function | 21 CFR 172.831, EU E 955 |
| Sucrose | 1× | Caramelizes; participates in Maillard reactions | Caloric; fermentable; cariogenic | GRAS; EU general food use |
| Aspartame | 180–200× | Hydrolyzes above 80–100°C depending on pH and time | Phenylalanine source; limited high-temperature use | 21 CFR 172.804, EU E 951 |
| Acesulfame potassium | 200× | Thermally stable | Bitter/metallic aftertaste at high concentrations | 21 CFR 172.800, EU E 950 |
| Saccharin | 300–500× | Thermally stable in acid systems | Bitter/metallic aftertaste; sodium or calcium salt forms | 21 CFR 180.37, EU E 954 |
| Steviol glycosides | 200–400× | Thermally stable | Licorice or bitter off-notes; slower onset and lingering | EU E 960; FDA GRAS notices |
Blends of sucralose with acesulfame potassium or aspartame exploit quantitative sweetener synergy, allowing total high-intensity sweetener usage to be reduced. The relative sweetness of sucralose increases in some fruit-flavoured systems and may decrease in high-protein or high-fat matrices; formulation-specific sweetness equivalency testing against sucrose reference solutions is required to establish dosage. In dairy products, the clean sweetness profile is retained through pasteurization and fermentation, but sucralose does not contribute to viscosity, freezing-point depression, or protein stabilisation. In frozen desserts, the loss of sucrose functionality must be offset with polyols, soluble fibres, or hydrocolloids to maintain ice-crystal control and scoopability.
Pharmaceutical-grade sucralose is used in oral solutions, chewable tablets, suspensions, and effervescent dosage forms. Compatibility with common excipients such as microcrystalline cellulose, mannitol, sorbitol, and citrate buffers is generally acceptable, but formulations containing strong oxidizers or strongly alkaline effervescent systems should be subjected to ICH Q1A forced-degradation testing. For dry powder inhalation or parenteral formulations, published data for this specific configuration is limited; particle-size distribution, residual solvent profile, and pyrogen burden must be specified directly against the intended pharmacopoeial monograph rather than inferred from food-grade material.